Chimeric antigen receptor (CAR) T-cell therapy ? What is this?
www.BeGenomics.com
BeGenomics.com
Chimeric antigen receptor T cells (CAR T cells) are T cells that have been genetically engineered to produce an artificial T cell receptor for use in immunotherapy.
www.BeGenomics.com
BeGenomics.com
www.BeGenomics.com
Photo credit: Cancer Research UK
BeGenomics.com
Chimeric antigen receptor (CAR) T-cell therapy represents a major advancement in personalized cancer treatment.
www.BeGenomics.com
BeGenomics.com
A type of treatment in which a patient's T cells are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient’s blood.
www.BeGenomics.com
BeGenomics.com
Then the gene for a special receptor that binds to a certain protein on the patient’s cancercells is added to the T cells in the lab. The special receptor is called a chimeric antigen receptor.
BeGenomics.com
CART-cell therapy is a way to get immune cells called T cells to fight cancer by changing them in the lab so they can find and destroy cancer cells.
www.BeGenomics.com
BeGenomics.com
CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
www.BeGenomics.com
BeGenomics.com
www.BeGenomics.com
FDA approved CAR-TCell therapies
BeGenomics.com
CAR T-cell therapy is available for some children with leukaemia and some adults with lymphoma.